Inducible expression of the alpha1-acid glycoprotein by rat and human type II alveolar epithelial cells.
Alpha1-acid glycoprotein (AGP) is a major acute phase protein in rat and human. AGP has important immunomodulatory functions that are potentially important for pulmonary inflammatory response. The liver is the main tissue for AGP synthesis in the organism, but the expression of AGP in the rat lung has not been investigated. We show that AGP mRNA was induced in the lung of dexamethasone-, turpentine-, or LPS-treated rats, whereas AGP mRNA was not detected in the lung of control rats. In the lung of animals treated intratracheally with LPS, in situ hybridization showed that AGP gene expression was restricted to cells located in the corners of the alveolus, consistent with an alveolar type II (ATII) cell localization. The inducible expression of the AGP gene was confirmed in vitro with SV40 T2 cells and rat ATII cells in primary culture: maximal expression required the presence of dexamethasone. IL-1 and the conditioned medium of alveolar macrophages acted synergistically with dexamethasone. Rat ATII cells secreted immunoreactive AGP in vitro when stimulated with dexamethasone or with a combination of dexamethasone and the conditioned medium of alveolar macrophages. In vivo, in the human lung, we detected immunoreactive AGP in hyperplastic ATII cells, whereas we did not detect AGP in the normal lung. We conclude that AGP is expressed in the lung in cases of inflammation and that ATII cells are the main source of AGP in the lung.
Crestani
B
B
Institut National de la Santé et de la Recherche Médicale U408, Faculté de Médecine Xavier Bichat, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, France. bruno.crestani@bch.ap-hop-paris.fr
Rolland
C
C
Lardeux
B
B
Fournier
T
T
Bernuau
D
D
Poüs
C
C
Vissuzaine
C
C
Li
L
L
Aubier
M
M
D000209:Acute-Phase Proteins / Q000096:biosynthesis; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D017403:In Situ Hybridization; D007509:Irritants / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008168:Lung / Q000166:cytology / Q000378:metabolism*; D016676:Macrophages, Alveolar / Q000378:metabolism; D008297:Male; D009961:Orosomucoid / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014425:Turpentine / Q000494:pharmacology*
D000209:Acute-Phase Proteins; D000893:Anti-Inflammatory Agents; D017077:Culture Media, Conditioned; D007509:Irritants; D008070:Lipopolysaccharides; D009961:Orosomucoid; D012333:RNA, Messenger; D003907:Dexamethasone; D014425:Turpentine